✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-09

Taking a GLP-1 and Metformin Together: Why Physicians Sometimes Combine Them

How metformin and GLP-1 medications work differently, why a physician might prescribe both, and why the decision is never one to make on your own.

Yes, a GLP-1 medication and metformin are often taken together under medical supervision. They work through different mechanisms, so physicians sometimes combine them for patients with insulin resistance, prediabetes, or type 2 diabetes. The pairing is common in clinical practice and generally well tolerated, but the decision to combine, adjust, or stop either medication always belongs to your prescribing physician, never to the patient alone.

Medication vials at a licensed pharmacy

Why physicians sometimes pair a GLP-1 with metformin

The two medications approach metabolism from different directions. Metformin, an FDA-approved medication for type 2 diabetes, mainly reduces the amount of glucose the liver releases and improves how the body responds to insulin. GLP-1 medications such as semaglutide and tirzepatide act on appetite centers in the brain and slow stomach emptying, which helps many people eat less without a constant willpower battle.

Because the mechanisms complement each other rather than overlap, a physician may keep a patient on metformin while adding a GLP-1, especially when blood sugar problems are part of the picture. Many people who seek weight-loss care are already taking metformin prescribed by their primary care doctor or endocrinologist, and continuing it is often appropriate.

Is taking both at the same time safe?

For appropriately screened patients, the combination is widely used in clinical practice and generally well tolerated. The main practical issue is that both medications can cause digestive side effects such as nausea or loose stools, so the effects can stack, which is one reason GLP-1 dosing starts low and increases slowly. Neither metformin nor a GLP-1 alone typically causes low blood sugar, but the picture changes when insulin or certain other diabetes medications are involved, which is exactly the kind of detail a physician reviews before prescribing.

Ready to start?

$199 Skeptics’ Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

Long-term metformin use has also been associated with lower vitamin B-12 levels, so a physician may check B-12 in patients who have taken it for years. None of this makes the combination unsafe; it simply means it belongs under medical supervision rather than guesswork.

Who decides, and what that looks like at a supervised clinic

Medication combinations are always the physician's call. At New Hope Weight Loss, every plan begins with a $119 medical review with Dr. Anjmun Sharma, MD, that covers your full medication list, including metformin, along with your history and contraindications. If treatment is appropriate, programs use compounded semaglutide or compounded tirzepatide, which are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA. Brand medications such as Wegovy and Zepbound are the FDA-approved options for weight management. When a patient already takes metformin for diabetes, Dr. Sharma coordinates with the prescriber who manages that condition rather than working around them.

What to bring up before you start

Do not stop, restart, or change the dose of metformin on your own when beginning a GLP-1. Instead, give your physician the full picture:

With that information, the physician can decide whether combining makes sense for you, what monitoring is needed, and how the plan should adjust over time.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Can I take metformin and a GLP-1 like semaglutide at the same time?

Often yes. Physicians commonly prescribe them together because they work through different mechanisms, but whether the combination is right for you is a medical decision made after reviewing your history and medications.

Does metformin cause weight loss on its own?

Metformin is associated with modest weight effects for some people, but it is not a weight-loss medication in the way GLP-1s are. It is FDA-approved for type 2 diabetes, and any weight benefit varies from person to person.

Will taking both medications make side effects worse?

Both can cause digestive side effects such as nausea, so effects can overlap, especially at the start. Physicians manage this by starting GLP-1 doses low and increasing slowly, and by adjusting the plan if symptoms persist.

Should I stop metformin when I start a GLP-1?

Not on your own. Many patients continue metformin alongside a GLP-1, and stopping it can affect blood sugar control. Any change to metformin should come from the physician who prescribed it or in coordination with them.

Do I need to tell the clinic I take metformin before starting a compounded GLP-1?

Yes, always. Your full medication list is reviewed during the $119 medical evaluation with Dr. Sharma so the treatment plan and any monitoring, such as B-12 levels with long-term metformin use, can be set up safely.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.